Will fluoroquinolones ever be recommended for common infections in children?

Affiliations

Editorial

Urs B Schaad. Pediatr Infect Dis J. 2007 Oct.

. 2007 Oct;26(10):865-7.

doi: 10.1097/INF.0b013e3180cc20e4.

¹ University Children's Hospital, University of Basel, Basel, Switzerland. urs-b.schaad@unibas.ch

No abstract available

Comment on

Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
Bradley JS, Arguedas A, Blumer JL, Sáez-Llorens X, Melkote R, Noel GJ. Bradley JS, et al. Pediatr Infect Dis J. 2007 Oct;26(10):868-78. doi: 10.1097/INF.0b013e3180cbd2c7. Pediatr Infect Dis J. 2007. PMID: 17901791 Clinical Trial.
Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders.
Noel GJ, Bradley JS, Kauffman RE, Duffy CM, Gerbino PG, Arguedas A, Bagchi P, Balis DA, Blumer JL. Noel GJ, et al. Pediatr Infect Dis J. 2007 Oct;26(10):879-91. doi: 10.1097/INF.0b013e3180cbd382. Pediatr Infect Dis J. 2007. PMID: 17901792 Clinical Trial.